Phenibut HCL (250mg/capsule), 60 Capsules — Research Overview

Phenibut HCl (β-phenyl-γ-aminobutyric acid hydrochloride) is a hydrophilic GABA derivative featuring a hydrochloride salt modification, which enhances solubility and stability in aqueous environments. The phenyl substitution allows for increased lipophilicity and receptor affinity, distinguishing it from native GABA.

This compound primarily interacts with GABA_B receptors, modulating neurotransmitter signaling pathways. It undergoes hepatic metabolism via deamination and conjugation, with renal clearance as the primary excretion route. The capsule formulation ensures precise dosing and controlled delivery for research applications.

• High Purity – 99% Purity Guaranteed
• Independently Lab Tested
• Research Grade Quality
• For Laboratory Research Use Only

Intended use: This material is supplied for laboratory and in-vitro research only. It is not a drug, food, or cosmetic and is not intended for human or animal consumption.

Phenibut HCL (250mg/capsule), 60 Capsules Research Applications

Detailed research information for this product will be added soon.

Phenibut HCL (250mg/capsule), 60 Capsules Lab Results & Certificates of Analysis

Third-party analytical reports associated with this research compound:

• Phenibut HCL (HPLC) — January 21, 2026

Research Use Disclaimer

All product information is provided for educational and laboratory research reference only. Any form of introduction into humans or animals is prohibited. Handle only in licensed research settings in accordance with applicable laws and institutional protocols.